Cite
HARVARD Citation
Ricard, L. et al. (2019). Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib. Annals of the rheumatic diseases. 78 (4), pp. 539-. [Online].